Physician
Pediatric Partners El Paso, PA
Pediatric Partners El Paso, PA was paid $5.75M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoPEDIATRIC PARTNERS EL PASO, PA
EL PASO, TX 79936
EL PASO, TX 79936
33aNPI1144630682assigned 05/06/2014
33bProvider typePediatrics Physician
28Total paid$5.75M
24GClaims346,588
24DCodes billed100
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#71 of 1,136
Median peer was paid$329K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 472 | $10K | |
| 2019 | 792 | $20K | |
| 2020 | 13,635 | $275K | |
| 2021 | 90,198 | $1.42M | |
| 2022 | 99,463 | $1.58M | |
| 2023 | 76,665 | $1.31M | |
| 2024incomplete | 65,363 | $1.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 40,193 | 37,097 | $1.37M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 38,502 | 34,718 | $958K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.9% | 8,475 | 8,336 | $509K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.3% | 8,489 | 8,351 | $479K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.0% | 6,710 | 6,369 | $401K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.0% | 42,880 | 20,105 | $347K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.8% | 5,460 | 5,358 | $336K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.0% | 29,726 | 27,909 | $286K |
| 87428 | 4.0% | 7,327 | 7,065 | $232K | |
| 99429 | 2.9% | 6,735 | 6,617 | $164K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 2,129 | 2,083 | $75K |
| 99463 | <1% | 515 | 508 | $57K |
88 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 7,572 | $48K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 832 | $46K |
| 99499 | <1% | 994 | $46K | |
| 90461 | <1% | 10,618 | $36K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 517 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,982 | $28K |
| 0071A | <1% | 835 | $23K | |
| 83655 | <1% | 2,954 | $22K | |
| 0072A | <1% | 793 | $21K | |
| 90480 | <1% | 878 | $20K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 357 | $17K |
| 92551 | <1% | 17,197 | $16K | |
| 99381 | <1% | 181 | $13K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 169 | $13K |
| 0124A | <1% | 308 | $12K | |
| 93000 | <1% | 1,150 | $9K | |
| 99000 | <1% | 1,230 | $9K | |
| 0081A | <1% | 315 | $8K | |
| 0001A | <1% | 308 | $8K | |
| 0002A | <1% | 301 | $7K | |
| 90651 | <1% | 2,398 | $7K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 97 | $7K |
| 0154A | <1% | 270 | $6K | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | <1% | 279 | $6K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 504 | $5K |
| 99383 | <1% | 62 | $5K | |
| 0082A | <1% | 193 | $5K | |
| 0004A | <1% | 206 | $5K | |
| 96161 | <1% | 3,938 | $4K | |
| 0074A | <1% | 170 | $4K | |
| 94760 | <1% | 16,560 | $4K | |
| 96160 | <1% | 3,323 | $4K | |
| 90686 | <1% | 8,871 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 588 | $4K |
| 90620 | <1% | 900 | $4K | |
| 90619 | <1% | 1,344 | $3K | |
| 81002 | <1% | 1,423 | $3K | |
| 90677 | <1% | 1,150 | $3K | |
| 90710 | <1% | 2,493 | $3K | |
| 0003A | <1% | 95 | $2K | |
| 0083A | <1% | 72 | $2K | |
| 99384 | <1% | 13 | $1K | |
| 90680 | <1% | 3,637 | $1K | |
| 90670 | <1% | 4,321 | $1K | |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 86 | $783.30 |
| 99173 | <1% | 19,405 | $615.25 | |
| 90633 | <1% | 2,839 | $602.32 | |
| 85014 | <1% | 1,361 | $598.37 | |
| 85018 | <1% | 1,409 | $568.99 | |
| 90623 | <1% | 108 | $515.74 | |
| 90698 | <1% | 1,982 | $378.96 | |
| 87420 | <1% | 35 | $337.64 | |
| 90696 | <1% | 1,207 | $273.54 | |
| 0173A | <1% | 14 | $264.80 | |
| 90697 | <1% | 1,540 | $250.00 | |
| 90715 | <1% | 1,094 | $245.81 | |
| 96381 | <1% | 22 | $204.05 | |
| 96380 | <1% | 12 | $186.69 | |
| 90734 | <1% | 356 | $144.50 | |
| 90648 | <1% | 1,257 | $138.91 | |
| 91307 | <1% | 1,970 | $130.15 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 125 | $112.45 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $109.63 |
| 90744 | <1% | 758 | $107.27 | |
| 90700 | <1% | 1,307 | $52.74 | |
| 81025 | <1% | 12 | $49.58 | |
| 91300 | <1% | 1,116 | $15.93 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 71 | $9.12 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 45 | $2.25 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 57 | $1.55 |
| 91320 | <1% | 256 | $1.25 | |
| 90656 | <1% | 37 | $0.09 | |
| 91312 | <1% | 308 | $0.07 | |
| 91315 | <1% | 272 | $0.07 | |
| 90713 | <1% | 14 | $0.05 | |
| 91308 | <1% | 676 | $0.05 | |
| 91319 | <1% | 246 | $0.04 | |
| 91318 | <1% | 247 | $0.01 | |
| 99072 | 0% | 2,088 | $0.00 | |
| 90707 | 0% | 47 | $0.00 | |
| 90621 | 0% | 47 | $0.00 | |
| A4550 | Surgical trays | 0% | 20 | $0.00 |
| 99188 | 0% | 15 | $0.00 | |
| 36416 | 0% | 3,439 | $0.00 | |
| 90716 | 0% | 38 | $0.00 | |
| 91317 | 0% | 64 | $0.00 | |
| 90381 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRIETO, JOSE (PRESIDENT)